The management and prevention of vancomycin-resistant enterococci

Valentina Stosor*, Gary A. Noskin, Lance R. Peterson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Within the past 5 years, vancomycin-resistant enterococci (VRE) have swept throughout the US and Europe. Many of these organisms are also highly resistant to β-lactams and aminoglycosides, thereby making them virtually unbeatable. Optimal therapy for these infections is unknown despite extremely high mortality rates for patients with VRE bacteremia. Until effective therapy is available, prevention of transmission by adequate infection control procedures and judicious antibiotic use is critical.

Original languageEnglish (US)
Pages (from-to)487-488+493
JournalInfections in Medicine
Issue number6
StatePublished - Jun 1 1996


  • Drug resistance
  • Enterococci
  • Vancomycin

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'The management and prevention of vancomycin-resistant enterococci'. Together they form a unique fingerprint.

Cite this